Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Inno4Vac Workshop Report Part 2: RSV‐Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UK

Influenza and Other Respiratory Viruses(2024)10.1111/irv.70013Source: DataRank Database

Inno4Vac Workshop Report Part 2: RSV‐Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UK is a research paper published in Influenza and Other Respiratory Viruses (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.58)OA: goldTopics (34)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Rebecca Jane Cox ORCID,Othmar G. Engelhardt ORCID,Stephanie Ascough ORCID,Albert Osterhaus ORCID,Guus F. Rimmelzwaan ORCID

Live enrichment

PubMed:39440808 PMC:PMC11497170 OpenAlex:https://openalex.org/W4403687396

Innovative Medicines Initiative

Grant: 101007799

Innovations to accelerate vaccine development and manufacture

Division of Intramural Research

Grant: ZIA AI000326

National Institutes of Health

Grant: 1ZIAAI000326-32

Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses

Wellcome Trust

Grant: unidentified

unidentified

FWCI

0.58

Citation Percentile

0.7%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/irv.70013

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/irv.70013

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/irv.70013

journalhttps://doi.org/10.1111/irv.70013

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39440808

Fields of Study

Respiratory viral infections researchInfluenza Virus Research StudiesPneumonia and Respiratory Infections

MeSH Terms

Vaccine DevelopmentAnimalsUnited KingdomHumansInfluenza, HumanInfluenza VaccinesRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus Vaccines

Keywords

Immune systemVirusVirologyBiologyInfluenza A virusImmunologyRespiratory syncytial virus (RSV)Respiratory VirusesImmune AssaysControlled Human Infection Model (Chim)Correlates Of Protection (Cop)Influenza VaccinesRespiratory Syncytial Virus, HumanInfluenza, HumanVaccine DevelopmentRespiratory Syncytial Virus Vaccines610HumansAnimalsReview ArticleRespiratory Syncytial Virus InfectionsUnited Kingdom

Sustainable Development Goals

SDG 0: Good health and well-being